Healthcare provider profile · identity verified

Bindu Suresh, M.D.

Internal Medicine · TROY, MI · NPI 1063441723

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	584	204
Amlodipine Besylate	Amlodipine Besylate	526	169
Losartan Potassium	Losartan Potassium	486	158
Levothyroxine Sodium	Levothyroxine Sodium	462	133
Metformin Hcl	Metformin Hcl	282	91
Metoprolol Succinate	Metoprolol Succinate	278	85
Lisinopril	Lisinopril	276	92
Omeprazole	Omeprazole	262	93
Hydrochlorothiazide	Hydrochlorothiazide	238	79
Simvastatin	Simvastatin	195	59
Metoprolol Tartrate	Metoprolol Tartrate	188	57
Gabapentin	Gabapentin	186	64
Rosuvastatin Calcium	Rosuvastatin Calcium	183	68
Famotidine	Famotidine	168	74
Eliquis	Apixaban	140	44
Tramadol Hcl	Tramadol Hcl	135	30
Glimepiride	Glimepiride	131	38
Alprazolam	Alprazolam	118	36
Alendronate Sodium	Alendronate Sodium	106	41
Escitalopram Oxalate	Escitalopram Oxalate	93	36
Azithromycin	Azithromycin	92	82
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	90	18
Prednisone	Prednisone	77	63
Furosemide	Furosemide	72	28
Januvia	Sitagliptin Phosphate	69	15
Pantoprazole Sodium	Pantoprazole Sodium	66	19
Carvedilol	Carvedilol	65	24
Methocarbamol	Methocarbamol	65	48
Montelukast Sodium	Montelukast Sodium	65	26
Sertraline Hcl	Sertraline Hcl	65	20
Meloxicam	Meloxicam	64	31
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	62	24
Methylprednisolone	Methylprednisolone	59	56
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	55	18
Cephalexin	Cephalexin	54	47
Citalopram Hbr	Citalopram Hydrobromide	52	17
Pravastatin Sodium	Pravastatin Sodium	52	17
Duloxetine Hcl	Duloxetine Hcl	51	17
Jardiance	Empagliflozin	51	18
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	51	16
Allopurinol	Allopurinol	48	14
Breo Ellipta	Fluticasone/Vilanterol	48	14
Trazodone Hcl	Trazodone Hcl	48	20
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	47	15
Potassium Chloride	Potassium Chloride	47	17
Clopidogrel	Clopidogrel Bisulfate	44	16
Fluticasone Propionate	Fluticasone Propionate	44	23
Tamsulosin Hcl	Tamsulosin Hcl	44	19
Hydralazine Hcl	Hydralazine Hcl	40	14
Nifedipine Er	Nifedipine	40	11
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	40	17
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	39	13
Mirtazapine	Mirtazapine	39	15
Buspirone Hcl	Buspirone Hcl	38	14
Zolpidem Tartrate	Zolpidem Tartrate	38	11
Lovastatin	Lovastatin	37	suppressed
Ozempic	Semaglutide	37	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	36	25
Oxybutynin Chloride	Oxybutynin Chloride	36	14
Diclofenac Sodium	Diclofenac Sodium	35	17
Donepezil Hcl	Donepezil Hcl	35	15
Glipizide	Glipizide	34	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	34	11
Mounjaro	Tirzepatide	31	suppressed
Novolog Flexpen	Insulin Aspart	31	14
Xarelto	Rivaroxaban	31	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	30	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	29	25
Fenofibrate	Fenofibrate Nanocrystallized	29	11
Atenolol	Atenolol	27	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	27	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	26	17
Clonazepam	Clonazepam	25	suppressed
Betamethasone Dipropionate	Betamethasone Dipropionate	24	18
Farxiga	Dapagliflozin Propanediol	24	11
Metformin Hcl Er	Metformin Hcl	24	11
Olmesartan Medoxomil	Olmesartan Medoxomil	24	suppressed
Chlorthalidone	Chlorthalidone	22	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	21	suppressed
Valsartan	Valsartan	21	suppressed
Ezetimibe	Ezetimibe	20	suppressed
Memantine Hcl	Memantine Hcl	19	suppressed
Paroxetine Hcl	Paroxetine Hcl	19	suppressed
Primidone	Primidone	18	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	17	suppressed
Clarithromycin	Clarithromycin	16	14
Labetalol Hcl	Labetalol Hcl	16	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	16	suppressed
Repatha Sureclick	Evolocumab	16	suppressed
Synthroid	Levothyroxine Sodium	16	suppressed
Bupropion Xl	Bupropion Hcl	15	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	15	suppressed
Folic Acid	Folic Acid	15	suppressed
Nystatin	Nystatin	15	12
Spironolactone	Spironolactone	15	suppressed
Warfarin Sodium	Warfarin Sodium	15	suppressed
Bumetanide	Bumetanide	14	suppressed
Celecoxib	Celecoxib	14	suppressed
Clonidine Hcl	Clonidine Hcl	14	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	14	suppressed
Meclizine Hcl	Meclizine Hcl	14	12
Trulicity	Dulaglutide	14	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	14	suppressed
Benazepril Hcl	Benazepril Hcl	13	suppressed
Digoxin	Digoxin	13	suppressed
Lorazepam	Lorazepam	13	suppressed
Myrbetriq	Mirabegron	13	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	13	suppressed
Pregabalin	Pregabalin	13	suppressed
Repaglinide	Repaglinide	13	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	12	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	12	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	12	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	12	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	12	suppressed
Glipizide Er	Glipizide	12	suppressed
Klor-Con M10	Potassium Chloride	12	suppressed
Morphine Sulfate Er	Morphine Sulfate	12	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	12	suppressed
Propranolol Hcl Er	Propranolol Hcl	12	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	12	suppressed
Valacyclovir	Valacyclovir Hcl	12	11
Verapamil Er	Verapamil Hcl	12	suppressed
Advair Diskus	Fluticasone Propion/Salmeterol	11	suppressed
Fluconazole	Fluconazole	11	suppressed
Humalog Kwikpen U-100	Insulin Lispro	11	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	11	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error